ATE197249T1 - Stabiles arzneimittel enthaltend oxaliplatin - Google Patents

Stabiles arzneimittel enthaltend oxaliplatin

Info

Publication number: ATE197249T1
Authority: AT; Austria
Prior art keywords: pct; product containing; oxaliplatinum; medicinal product; containing oxaliplatin
Prior art date: 1994-08-08

Application number

AT95925976T

Other languages

English (en)

Inventor

Houssam Ibrahim

Rolland-Yves Mauvernay

Original Assignee

Debiopharm Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-08-08

Filing date

1995-08-07

Publication date

2000-11-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50845249&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE197249(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-08-07 Application filed by Debiopharm Sa filed Critical Debiopharm Sa

2000-11-15 Application granted granted Critical

2000-11-15 Publication of ATE197249T1 publication Critical patent/ATE197249T1/de

Links

229940126601 medicinal product Drugs 0.000 title 1
DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 title 1
229960001756 oxaliplatin Drugs 0.000 title 1
239000007864 aqueous solution Substances 0.000 abstract 1
238000007911 parenteral administration Methods 0.000 abstract 1
239000000243 solution Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT95925976T 1994-08-08 1995-08-07 Stabiles arzneimittel enthaltend oxaliplatin ATE197249T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CH246294		1994-08-08
PCT/IB1995/000614 WO1996004904A1 (fr)	1994-08-08	1995-08-07	Preparation pharmaceutiquement stable d'oxaliplatine

Publications (1)

Publication Number	Publication Date
ATE197249T1 true ATE197249T1 (de)	2000-11-15

Family

ID=50845249

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95925976T ATE197249T1 (de)	1994-08-08	1995-08-07	Stabiles arzneimittel enthaltend oxaliplatin

Country Status (17)

Country	Link
US (1)	US5716988A (de)
EP (1)	EP0774963B1 (de)
JP (1)	JP3547755B2 (de)
KR (1)	KR100365171B1 (de)
CN (1)	CN1138541C (de)
AT (1)	ATE197249T1 (de)
AU (2)	AU2989695A (de)
BR (1)	BR9508554A (de)
CA (1)	CA2196922C (de)
CZ (1)	CZ286714B6 (de)
DE (1)	DE69519300T2 (de)
DK (1)	DK0774963T3 (de)
ES (1)	ES2152412T3 (de)
IL (1)	IL114852A (de)
RU (1)	RU2148400C1 (de)
UA (1)	UA42779C2 (de)
WO (1)	WO1996004904A1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3547755B2 (ja)	1994-08-08	2004-07-28	デビオファーム・エス・アー	オキサリプラティヌムの医薬的に安定な製剤
GB9804013D0 (en) *	1998-02-25	1998-04-22	Sanofi Sa	Formulations
US6866857B1 (en) *	1998-10-14	2005-03-15	Debiopharm S.A.	Oxalipatinum preparation packaging
GB9904386D0 (en) *	1999-02-25	1999-04-21	Pharmacia & Upjohn Spa	Antitumour synergistic composition
US7070796B1 (en) *	1999-08-30	2006-07-04	Debiopharm S.A.	Pharmaceutically stable oxaliplatinum preparation for parenteral administration
CA2382389C (fr) *	1999-08-30	2010-06-29	Debiopharm S.A.	Preparation pharmaceutique stable d'oxaliplatine pour administration par voie parenterale
AU2002223013A1 (en) *	2000-12-12	2002-06-24	Debiopharm S.A.	Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same
EP1368022B1 (de)	2001-03-02	2007-06-20	Debiopharm S.A.	Verwendung eines eine oxaliplatinlösung beinhaltenden fläschchens
EP1404689A1 (de) *	2001-07-02	2004-04-07	Debiopharm S.A.	Aktive oxiplatinverbindung mit sehr niedrigem oxalsaüregehalt
TWI315982B (en)	2001-07-19	2009-10-21	Novartis Ag	Combinations comprising epothilones and pharmaceutical uses thereof
US6476068B1 (en)	2001-12-06	2002-11-05	Pharmacia Italia, S.P.A.	Platinum derivative pharmaceutical formulations
CA2388352A1 (en) *	2002-05-31	2003-11-30	Voiceage Corporation	A method and device for frequency-selective pitch enhancement of synthesized speed
US20040022842A1 (en) *	2002-06-03	2004-02-05	Mebiopharm Co., Ltd.	Liposome preparations containing oxaliplatin
CN102048723A (zh)	2003-08-28	2011-05-11	梅恩医药有限公司	含有酸的奥沙利铂制剂
ZA200604529B (en) *	2003-11-25	2007-12-27	Platco Technologies Proprietar	Platinum (II) complexes, preparation and use
CN100471493C (zh) *	2003-12-17	2009-03-25	梅比欧法姆股份有限公司	含有奥沙利铂的脂质体制剂
WO2005120480A1 (ja) *	2004-06-09	2005-12-22	Taiho Pharmaceutical Co., Ltd.	抗腫瘍効果増強剤、抗腫瘍剤及び癌治療方法
EP1789427B1 (de)	2004-09-01	2009-05-20	Platco Technologies (Proprietary) Limited	Herstellung von platin(ii)-komplexen
US20060063833A1 (en) *	2004-09-22	2006-03-23	Edgar Schridde	Ready-to-use oxaliplatin solutions
US20060063720A1 (en) *	2004-09-22	2006-03-23	Edgar Schridde	Oxaliplatin solution concentrate
DE102004052877B4 (de) *	2004-11-02	2008-06-19	Ebewe Pharma Ges.M.B.H. Nfg.Kg	Stabile wässrige Formulierungen eines Platin-Derivats
JP2006248978A (ja) *	2005-03-10	2006-09-21	Mebiopharm Co Ltd	新規なリポソーム製剤
WO2007029268A2 (en)	2005-09-05	2007-03-15	Dabur Pharma Limited	Stable oxaliplatin formulation
CN101389637A (zh)	2006-01-30	2009-03-18	普拉托技术（私有）公司	铂(ⅱ)配合物的制备
CN101442998B (zh) *	2006-03-16	2012-03-14	比奥纽默里克药物公司	抗癌活性加强化合物和制剂及其用法
US20090317489A1 (en)	2006-05-09	2009-12-24	Hanspeter Nick	Combination Comprising an Iron Chelator and an Anti-Neoplastic Agent and Use Thereof
BRPI0806596A2 (pt) *	2007-01-18	2013-07-23	Merck Patent Ges Mit Berchraenkter Haftung	medicamento e terapia especÍfica usando-se ligantes de integrina para o tratamento de cÂncer
US20090076139A1 (en) *	2007-09-19	2009-03-19	Protia, Llc	Deuterium-enriched oxalplatin
EP2152239A1 (de) *	2007-11-12	2010-02-17	Intas Pharmaceuticals Limited	Stabile oxaliplatinzusammensetzung zur parenteralen verabreichung
AU2008352597B2 (en)	2008-03-14	2012-03-08	Bionumerik Pharmaceuticals, Inc.	Treatment methods and compositions for lung cancer, adenocarcinoma, and other medical conditions
JP5667886B2 (ja)	2008-03-14	2015-02-12	バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド	癌患者の生存時間を増大させるための組成物及び化合物の使用方法
EP2481396A4 (de)	2009-09-21	2014-03-05	Jw Pharmaceutical Corp	Oxaliplatin-nanopartikel und herstellungsverfahren dafür
US20130096170A1 (en)	2011-10-14	2013-04-18	Hospira, Inc.	Methods of treating pediatric patients using dexmedetomidine
AU2013202575B1 (en) *	2012-01-04	2013-05-16	Hospira, Inc.	Dexmedetomidine premix formulation
US8242158B1 (en) *	2012-01-04	2012-08-14	Hospira, Inc.	Dexmedetomidine premix formulation
JP5314790B1 (ja) *	2012-07-09	2013-10-16	東和薬品株式会社	オキサリプラチン含有医薬組成物
EP2883542B1 (de)	2012-08-10	2019-05-01	Taiho Pharmaceutical Co., Ltd.	Stabile oxaliplatin-verkapselnde wässrige liposomdispersion und stabilisierungsverfahren dafür
MX2015003007A (es)	2012-09-07	2015-06-05	Coherus Biosciences Inc	Formulaciones acuosas estables de adalimumab.
CN103690494B (zh) *	2013-11-29	2015-04-15	杭州华东医药集团新药研究院有限公司	一种低杂质含有奥沙利铂的组合物及其制备方法
CA2953350C (en)	2014-06-23	2019-11-26	Placon Therapeutics, Inc.	Platinum compounds, compositions, and uses thereof
BR112018000254A2 (pt)	2015-07-07	2018-09-04	H Lundbeck As	inibidores de pde9 com cadeia principal de imidazotriazinona e cadeia principal de imidazopirazinona para o tratamento de doenças periféricas
CN104940151A (zh) *	2015-07-23	2015-09-30	青岛蓝盛洋医药生物科技有限责任公司	一种抗癌药物奥沙利铂冻干粉针剂组合物
US11229702B1 (en)	2015-10-28	2022-01-25	Coherus Biosciences, Inc.	High concentration formulations of adalimumab
WO2017184880A1 (en)	2016-04-20	2017-10-26	Coherus Biosciences, Inc.	A method of filling a container with no headspace
WO2017192290A1 (en)	2016-05-04	2017-11-09	The Wistar Institute Of Anatomy And Biology	Methods of treating cancers overexpressing carm1 with ezh2 inhibitors and platinum-based antineoplastic drugs
AU2017292650A1 (en)	2016-07-06	2018-12-13	H. Lundbeck A/S	PDE9 inhibitors for treatment of peripheral diseases
SI3630772T1 (sl)	2017-05-26	2024-05-31	Cardurion Pharmaceuticals, Inc.,	Postopki izdelave in uporabe zaviralcev pde9
EP3801526B1 (de)	2018-05-25	2023-12-27	Imara Inc.	Monohydrat und kristalline formen von 6-[(3s,4s)-4-methyl-1- (pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl- 7h-imid azo [1,5- a] pyrazin-8-on
CN112996512B (zh)	2018-08-31	2025-01-03	卡都瑞恩医药公司	用于治疗镰状细胞病的pde9抑制剂

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6041077B2 (ja) *	1976-09-06	1985-09-13	喜徳喜谷	１，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
US4657927A (en) *	1978-05-04	1987-04-14	Research Corporation	Malonato platinum compounds
IL83380A (en) *	1987-07-30	1991-04-15	Teva Pharma	Stable aqueous cisplatin solutions
NL8901433A (nl) *	1989-06-06	1991-01-02	Pharmachemie Bv	Carboplatinpreparaat.
JPH04185601A (ja) *	1990-11-20	1992-07-02	Unitika Ltd	白金抗癌剤徐放性製剤
JP2673331B2 (ja)	1993-01-12	1997-11-05	田中貴金属工業株式会社	光学的に高純度なシス―オキザラート（トランス―１―１，２―シクロヘキサンジアミン）白金（▲ｉｉ▼）
WO1994012193A1 (fr) *	1992-11-24	1994-06-09	Debiopharm S.A.	Combinaison de cisplatine avec l'oxaliplatine
US5455270A (en) *	1993-08-11	1995-10-03	Bristol-Myers Squibb Co.	Stabilized solutions of platinum(II) antitumor agents
JP3547755B2 (ja)	1994-08-08	2004-07-28	デビオファーム・エス・アー	オキサリプラティヌムの医薬的に安定な製剤

1995
- 1995-08-07 JP JP50715996A patent/JP3547755B2/ja not_active Expired - Lifetime
- 1995-08-07 AT AT95925976T patent/ATE197249T1/de not_active IP Right Cessation
- 1995-08-07 CZ CZ1997379A patent/CZ286714B6/cs not_active IP Right Cessation
- 1995-08-07 CN CNB951944436A patent/CN1138541C/zh not_active Expired - Lifetime
- 1995-08-07 DE DE69519300T patent/DE69519300T2/de not_active Expired - Lifetime
- 1995-08-07 IL IL11485295A patent/IL114852A/xx not_active IP Right Cessation
- 1995-08-07 CA CA002196922A patent/CA2196922C/fr not_active Expired - Lifetime
- 1995-08-07 US US08/776,240 patent/US5716988A/en not_active Expired - Lifetime
- 1995-08-07 AU AU29896/95A patent/AU2989695A/en not_active Abandoned
- 1995-08-07 ES ES95925976T patent/ES2152412T3/es not_active Expired - Lifetime
- 1995-08-07 EP EP95925976A patent/EP0774963B1/de not_active Expired - Lifetime
- 1995-08-07 DK DK95925976T patent/DK0774963T3/da active
- 1995-08-07 BR BR9508554A patent/BR9508554A/pt not_active IP Right Cessation
- 1995-08-07 UA UA97010366A patent/UA42779C2/uk unknown
- 1995-08-07 WO PCT/IB1995/000614 patent/WO1996004904A1/fr not_active Ceased
- 1995-08-07 RU RU97104030A patent/RU2148400C1/ru not_active IP Right Cessation
- 1995-08-07 KR KR1019970700780A patent/KR100365171B1/ko not_active Ceased
1999
- 1999-03-31 AU AU22524/99A patent/AU731981B2/en not_active Expired

Also Published As

Publication number	Publication date
CA2196922A1 (fr)	1996-02-22
DE69519300T2 (de)	2001-05-31
KR970704434A (ko)	1997-09-06
RU2148400C1 (ru)	2000-05-10
IL114852A0 (en)	1995-12-08
CA2196922C (fr)	2004-06-01
UA42779C2 (uk)	2001-11-15
CN1154654A (zh)	1997-07-16
AU2989695A (en)	2000-03-07
ES2152412T3 (es)	2001-02-01
CZ286714B6 (en)	2000-06-14
KR100365171B1 (ko)	2003-02-19
AU731981B2 (en)	2001-04-12
DE69519300D1 (de)	2000-12-07
EP0774963B1 (de)	2000-11-02
AU2252499A (en)	2000-03-23
CN1138541C (zh)	2004-02-18
IL114852A (en)	2000-02-29
WO1996004904A1 (fr)	1996-02-22
CZ37997A3 (en)	1997-06-11
US5716988A (en)	1998-02-10
EP0774963A1 (de)	1997-05-28
BR9508554A (pt)	1997-11-25
JP3547755B2 (ja)	2004-07-28
DK0774963T3 (da)	2001-01-29
JPH10508289A (ja)	1998-08-18

Legal Events

Date	Code	Title
2001-04-15	UEP	Publication of translation of european patent specification
2010-12-15	EELV	Lapsed due to withdrawal
2011-01-15	REZ	Deleted due to withdrawal

Publication	Publication Date	Title
DE69519300D1 (de)	2000-12-07	Stabiles arzneimittel enthaltend oxaliplatin
ZA912793B (en)	1992-12-30	Pharmaceutical formulations
RU94040387A (ru)	1996-10-20	Композиция, способствующая прекращению курения, никотиносодержащий распыляемый раствор, способ снижения потребности в курении табака, способ замены курения табака
PL325825A1 (en)	1998-08-03	Microemulsion for use as a carrier for administering active compounds
KR920702216A (ko)	1992-09-03	아세틸 d-카르니틴의 녹내장 치료에의 용도
IT1270594B (it)	1997-05-07	Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
AU2001288460A1 (en)	2002-03-22	Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant
MXPA02008654A (es)	2004-09-06	Formulaciones de ranolazina de liberacion prolongada.
ATE401892T1 (de)	2008-08-15	Verwendung von pharmazeutischen zubereitungen enthaltend oxcarbazepin im nüchternzustand
NO20023684D0 (no)	2002-08-02	Pediatrisk formulering
BR9913626A (pt)	2001-12-04	Formulações de ranolazina de liberação contìnua
KR920007629A (ko)	1992-05-27	SALMe염, 5-MTHF 및 5-FTHF 중에서 선택된 화합물 적어도 1개를 유효성분으로서 함유하여 AIDS환자의 신경학적 질환치료시 활성을 나타내는 약제학적 조성물
CA2215327A1 (en)	1996-10-31	Formulations for lipophilic compounds
KR970025615A (ko)	1997-06-24	암 전이 억제제
KR830002510A (ko)	1983-05-30	생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물
KR880007060A (ko)	1988-08-26	제약 조성물
EE04264B1 (et)	2004-04-15	Naatriumkloriidi kasutamine aine valmistamiseks kamptotetsiini derivaatide manustamisest tingitud gastrointestinaalsete kõrvaltoimete vähendamiseks
GB1487334A (en)	1977-09-28	Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof
AU2001289762A1 (en)	2002-02-13	Pharmaceutical extemporary compositions
KR870009716A (ko)	1987-11-30	클로르페니라민 제형
ES404959A1 (es)	1975-07-01	Un procedimiento para preparar una composicion acuosa es- table de dexiciclina.
ATE203903T1 (de)	2001-08-15	Delta-aminolävulinsäure enthaltendes arzneimittel
HUP9802005A2 (hu)	1999-04-28	Nátrium/hidrogén-csere inhibitorok alkalmazása különböző anyagok által a szívre gyakorolt nem kívánt hatások csökkentésére alkalmas gyógyszerkészítmények előállítására
PL350413A1 (en)	2002-12-02	Pharmaceutical effervescent formulation containing metamizol
KR900701263A (ko)	1990-12-01	이보파민의 수용성 산 부가 염을 포함하는 안과용 약학 조성물